Clinical characteristics of ALK plus NSCLC patients (pts) treated with crizotinib beyond disease progression (PD): Potential implications for management Meeting Abstract
| Authors: | Otterson, G. A.; Riely, G. J.; Shaw, A. T.; Crino, L.; Kim, D. W.; Martins, R.; Salgia, R.; Zhou, C.; Solomon, B. J.; Wilner, K. D.; Polli, A.; Tang, Y.; Bartlett, C. H.; Ou, S. H. I. |
| Abstract Title: | Clinical characteristics of ALK plus NSCLC patients (pts) treated with crizotinib beyond disease progression (PD): Potential implications for management |
| Meeting Title: | 48th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 30 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2012 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2012-05-20 |
| Language: | English |
| ACCESSION: | WOS:000318009804095 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2012.30.15_suppl.7600 |
| Notes: | Meeting Abstract: 7600 -- Source: Wos |
